Clinical Trial Update: Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating the safety of Ramelteon in subjects with mild to moderate chronic obstructive pulmonary disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | Status: COMPLETED